This NDC is on FDA's drug shortage list (posted Feb 8, 2019)
Product Information
DEXAMETHASONE 10 MG/ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.1568 per ML under NDC 63323050601. Its NADAC has been published 94 times since Jul 17, 2024.
FDA first approved this application on Apr 11, 2003. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323050601
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA040491FDA Approved
4/11/2003
TE Code
AP
On Market Since
5/29/2003
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 10 MG/ML VIAL has been published 94 times since Jul 17, 2024, and over the history we have for it it has declined 69.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1568 per ML |
|---|---|
| All-time high | $3.8354 (Aug 13, 2025) |
| All-time low | $1.1568 (Sep 23, 2026) |
| 52-week high | $1.9328 |
| 52-week low | $1.1568 |
| Median price | $3.8354 |
| Average price | $2.9868 |
| Largest weekly change | -49.6% (Jan 21, 2026) |
| Weeks tracked | 94 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXAMETHASONE SODIUM PHOSPHATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 10 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 10 MG/ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $1.1568 per ML (NDC 63323050601), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 10 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 10 MG/ML VIAL has declined 69.8%. It has been tracked across 94 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 10 MG/ML VIAL?
Since Jul 17, 2024, the NADAC for DEXAMETHASONE 10 MG/ML VIAL has ranged from a low of $1.1568 (Sep 23, 2026) to a high of $3.8354 (Aug 13, 2025), with a median of $3.8354 per ML.
Are there cheaper alternatives to DEXAMETHASONE 10 MG/ML VIAL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXAMETHASONE 100 MG/10 ML VL, is $0.5104 per ML — about 56% below DEXAMETHASONE 10 MG/ML VIAL.
Who manufactures DEXAMETHASONE 10 MG/ML VIAL?
DEXAMETHASONE 10 MG/ML VIAL (NDC 63323050601) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Is DEXAMETHASONE 10 MG/ML VIAL in shortage?
Yes — NDC 63323050601 is currently listed in FDA's drug shortage database (posted Feb 8, 2019).